A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

Invest New Drugs. 2005 Jun;23(3):241-2. doi: 10.1007/s10637-005-6732-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adult
  • Amifostine / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology*
  • Cytoprotection
  • Dose-Response Relationship, Drug
  • Humans
  • Irinotecan
  • Neoplasm Metastasis

Substances

  • Irinotecan
  • Amifostine
  • Camptothecin